Myristoyl Pentapeptide 17
AKA “Myristoyl Pentapeptide-17, 959610-30-1, MFCD30533241, N-((5S, 8S, 11S, 14S, 17S)-1, 21-diamino-8-(4-aminobutyl)-5-carbamoyl-14-isobutyl-11-methyl-7, 10, 13, 16-tetraoxo-6, 9, 12, 15-tetraazahenicosan-17-yl)tetradecanamide, N-[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1, 6-diamino-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]tetradecanamide, MyristoylPentapeptide-17, Myristoyl Pentapeptide-17?, orb1705173, SCHEMBL30286903, NFPWMUOQSJXGGZ-ZZTWKDBPSA-N
Synthetic
Ingredient Facts
Myristoyl pentapeptide 17
AKA: Myristoyl Pentapeptide-17, 959610-30-1, MFCD30533241, N-((5S, 8S, 11S, 14S, 17S)-1, 21-diamino-8-(4-aminobutyl)-5-carbamoyl-14-isobutyl-11-methyl-7, 10, 13, 16-tetraoxo-6, 9, 12, 15-tetraazahenicosan-17-yl)tetradecanamide, N-[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1, 6-diamino-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]tetradecanamide, MyristoylPentapeptide-17, Myristoyl Pentapeptide-17?, Orb1705173, SCHEMBL30286903, NFPWMUOQSJXGGZ-ZZTWKDBPSA-N
Synthetic · Skin Conditioning · EWG: 1
Synthetic
Skin Conditioner
Amino Acid
Synthetic
Clean
Myristoyl Pentapeptide 17 is a cosmetic ingredient. Also known as Myristoyl Pentapeptide-17. Rated low hazard by EWG.
Formula
C41H81N9O6
Mol. Weight
796.10
CAS #
959610-30-1
Form
Powder
See origin →
Functions
Skin Conditioning
A catch-all term for ingredients that improve how skin looks and feels — softer, smoother, more supple. The workhorse behind most moisturizers.
Skin Conditioning Miscellaneous
Improves skin feel
Traditional Use
This is a chemical registry number without a corresponding INCI name; unable to provide traditional use information.
Skin Types
all-skin-types
Best For
General
EWG
1
CIR
Insufficient
Pregnancy
CIR Safety Findings
all-shades-safe
Regulatory Status
USAunder review
CANADApermitted
Regulatory Agencies
Verified Jun 2026
Data: PubChem · CosIng · EWG · CIR